CJMB insider transaction filings
CALLAN JMB INC. — 11 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-01. Screen CJMB transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-01 | 4 | Dial Gerald — Director | Purchase (P): 10,000 @ $0.76 · Grant/award (A): 25,000 (derivative) @ $4 | EDGAR |
| 2026-03-26 | 4 | Croyle David J — Chief Medical Officer, 10% owner | Purchase (P): 10,195 @ $1.75 | EDGAR |
| 2026-03-10 | 4 | Croyle David J — Chief Medical Officer, 10% owner | Purchase (P): 14,805 @ $1.76 | EDGAR |
| 2026-01-06 | 4 | Dial Gerald — Director | Purchase (P): 461 @ $1.22 · Purchase (P): 1,539 @ $1.20 · Grant/award (A): 25,000 (derivative) @ $4 | EDGAR |
| 2025-12-18 | 4 | Williams Wayne D — CEO, Chairman and President, Director, 10% owner | Purchase (P): 5,000 @ $1.73 | EDGAR |
| 2025-12-15 | 4 | Williams Wayne D — CEO, Chairman and President, Director, 10% owner | Purchase (P): 62 @ $1.79 · Purchase (P): 4,926 @ $1.75 · Purchase (P): 10,810 @ $1.70 | EDGAR |
| 2025-12-12 | 4 | Williams Wayne D — CEO, Chairman and President, Director, 10% owner | Purchase (P): 13,689 @ $1.65 · Purchase (P): 30,856 @ $1.65 | EDGAR |
| 2025-12-10 | 4 | Duke Liberty Smith — Director | Purchase (P): 900 @ $1.56 · Purchase (P): 612 @ $1.52 · Grant/award (A): 25,000 (derivative) @ $4 | EDGAR |
| 2025-04-03 | 4 | Croyle David J — Chief Medical Officer, 10% owner | Purchase (P): 25,000 @ $4.50 | EDGAR |
| 2025-03-14 | 4 | Williams Wayne D — CEO and President, Director, 10% owner | Purchase (P): 12,500 @ $4 · Purchase (P): 25,625 @ $4 · Purchase (P): 25,000 @ $4 | EDGAR |
| 2025-03-14 | 4 | Croyle David J — Chief Medical Officer, 10% owner | Purchase (P): 24,375 @ $4 | EDGAR |
Recent 8-K events — CALLAN JMB INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-06-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-10 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-03-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-31 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-12-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CJMB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →